Nucleoprotein-derived and unbound ribonucleosides: Bioactivity and potential applications

Current Pharmaceutical Design

Volumn 13, Issue 9, 2007, Pages 921-932

  Martin, Dierk ^a   Meisel, Hans ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

Author keywords

Bioactivity; Cytochemistry; Food; Marker molecules; Pharmaceutical; Ribonucleosides; Technological treatment

Indexed keywords

2 FLUOROADENOSINE; 6 BENZYLTHIOINOSINE DERIVATIVE; ANTINEOPLASTIC AGENT; CAFFEINE; CAPECITABINE; CLADRIBINE; CORDYCEPIN; CORDYCEPS SINENSIS EXTRACT; CYTARABINE; DEOXYURIDINE; DEXTRO 2',3' DIDEHYDRO 2',3' DIDEOXY 2' FLUORO 4' THIONUCLEOSIDE DERIVATIVE; DIDANOSINE; DOXIFLURIDINE; ERGOSTEROL; FLOXURIDINE; FLUDARABINE; FLUOROURIDINE; LAMIVUDINE; NELFINAVIR; NICOTINE; NUCLEOPROTEIN; NUCLEOSIDE DERIVATIVE; PURINE NUCLEOSIDE DERIVATIVE; PYRIMIDINE NUCLEOSIDE DERIVATIVE; RIBONUCLEOSIDE; RIBONUCLEOTIDE; STAVUDINE; TENOFOVIR DISOPROXIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BINDING AFFINITY; CELL PROLIFERATION; CLINICAL TRIAL; COLORECTAL CANCER; CORDYCEPS; CORDYCEPS KYUSHUENSI; CORDYCEPS MILITARIS; CYTOCHEMISTRY; DIETARY INTAKE; DIGESTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SYNTHESIS; FOOD COMPOSITION; FUNCTIONAL FOOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; INTESTINE CELL; IRON ABSORPTION; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRIAL TOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL SURVIVAL; CELLS, CULTURED; HUMANS; MEAT; MILK; MILK, HUMAN; NEOPLASMS; NUCLEOPROTEINS; RIBONUCLEOSIDES;

EID: 34247220795     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207780414269     Document Type: Review

References (111)

1. Harmon RE, Robins RK, Townsend LB Ed, Chemistry and biology of nucleosides and nucleotides. New York, Academic Press 1978.
2. Quan R, Barness LA, Uauy R. Do infants need nucleotide supplemented formula for optimal nutrition? J Pediatr Gastroenterol Nutr 1990; 11(4): 429-34.
3. Thorell L, Sjoberg LB, Hernell O. Nucleotides in human milk: sources and metabolism by the newborn infant. Pediatr Res 1996; 40(6): 845-52.
4. Jarvis SM. In: Gil A, Uauy R Ed, Nutritional and biological significance of dietary nucleotides and nucleic acids. Granada, Abbott Laboratories 1996; 87-110.
5. Belt JA, Noel LD. Isolation and characterization of a mutant of L1210 murine leukemia deficient in nitrobenzylthioinosineinsensitive nucleoside transport. J Biol Chem 1988; 263: 13819-22.
6. Vijayalakshmi D, Dagnino L, Belt JA, Gati WP, Cass CE, Paterson ARP. L1210/B23.1 cells express equilibrative, inhibitor-sensitive nucleoside transport activity and lack two parental nucleoside transport activities. J Biol Chem 1992; 267: 16951-6.
7. Aronow B, Toll D, Patrick J, Hollingsworth P, McCartan K, Ullman B. Expression of a novel high-affinity purine nucleobase transport function in mutant mammalian T-lymphoblasts. Mol Cell Biol 1986; 6(8): 2957-62.
8. Ullman B, Patrick J, McCartan K. Expression of the high-affinity purine nucleobase transporter in mutant mouse S49 cells does not require a functional wild-type nucleoside-nucleobase transporter. Mol Cell Biol 1987; 7(1): 97-103.
9. Yao SYM, Ng AML, Vickers MF, Sundaram M, Cass CE, Baldwin SA, et al. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. J Biol Chem 2002; 277: 24938-48.
10. Wallace LJM, Candlish D, DeKoning HP. Different substrate recognition motifs of human and trypanosome nucleobase transporters. J Biol Chem 2002; 277: 26149-56.
11. Plagemann PGW, Wohlheuter RM. Hypoxanthine transport in mammalian-cells: cell type-specific differences in sensitivity to inhibition by dipyridamole and uridine. J Membr Biol 1984; 81(3): 255-62.
12. Griffith DA, Jarvis SM. High affinity sodium-dependent nucleobase transport in cultured renal epithelial cells (LLC-PK1). J Biol Chem 1993; 268(27): 20085-90.
13. Bronk JR, Hastewell JG. The transport of pyrimidines into tissue rings cut from rat small intestine. J Physiol (London) 1987; 382: 475-88.
14. Le Hir M, Dubach UC. Concentrative transport of purine nucleosides in brush border vesicles of the rat kidney. Eur J Clin Invest 1985; 15(3): 121-7.
15. +-dependent uridine transport in rat renal brush-border membrane vesicles. Biochim Biophys Acta 1988; 942(1): 139-49.
16. Jarvis SM. Characterization of sodium-dependent nucleoside transport in rabbit intestinal brush-border membrane vesicles. Biochim Biophys Acta 1989; 979(1): 132-8.
17. Darnowski JW, Holdridge C, Hondschumacher RE. Concentrative uridine transport by murine splenocytes: kinetics, substrate specificity, and sodium dependency. Cancer Res 1987; 47(10): 2614-9.
18. Williams TC, Jarvis SM. Multiple sodium-dependent nucleoside transport systems in bovine renal brush-border membrane vesicles. Biochem J 1991; 274: 27-33.
19. Gutierrez MM, Brett CM, Ott RJ, Hui AC, Giacomini KM. Nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta 1992; 1105(1): 1-9.
20. +-nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta 1993; 1149(2): 202-8.
21. Uauy R. In: Lebenthal E Ed, Text book of Gastroenterology and Nutrition in Infancy. 2nd Edition, New York, Raven Press Ltd. 1989; 265-80.
22. Pickering LK, Granoff DM, Erickson JR, Marson ML, Cordle CT, Shaller JP, et al. Modulation of immune system by human milk and infant formula containing nucleotides. Pediatrics 1998; 101: 242-9.
23. Schlimme E, Martin D. Supplementation of infant formulae with nucleotides. Kieler Milchw Forsch 1999; 51: 215-24.
24. Molina JA, Romera JM, Gil A. In: Gil A, Uauy R Ed, Nutritional and biological significance of dietary nucleotides and nucleic acids. Granada, Publ. by Abbott Laboratories 1996; 63-7.
25. Commission Directive 96/4/EC of 16 February 1996. Official Journal of the European Communities No L49, 1996.
26. Gil A. Modulation of the immune response mediated by dietary nucleotides. Eur J Clin Nutr 2002; 56(Suppl 3): S1-S4.
27. Schlimme E, Martin D, Meisel H. Nucleosides and nucleotides: natural bioactive substances in milk and colostrum. Br J Nutr 2000; 84(Suppl 1): S59-S68.
28. Buts JP. Milk-borne bioactive factors. Arch Pediatr 1998; 5: 298-306.
29. Cosgrove M. Nucleotides. Nutrition 1998; 14: 748-51.
30. Aggett P, Leach JL, Rueda R, MacLean WC. Innovation in infant formula development: A reassessment of ribonucleotides in 2002. Nutrition 2003; 19: 375-84.
31. Uauy R, Stringel G, Thomas R, Quan R. Effect of dietary nucleosides on growth and maturation of the developing gut in the rat. J Pediatr Gastroenterol Nutr 1990; 10: 497-503.
32. Leleiko NS, Bronstein AD, Baliga S, Munro HN. De novo purine nucleotide synthesis in the rat small and large intestine-effect of dietary protein and purines. J Pediatr Gastroenterol Nutr 1983; 2: 313-19.
33. Leleiko NS, Bronstein AD, Munro HN. Effect of dietary purines on de novo synthesis of purine nucleotides in the small intestinal mucosa. Pediatr Res 1979; 13: 403.
34. Leleiko NS, Martin BA, Walsh M, Kazlow P, Rabinowitz S, Sterling K. Tissue-specific gene-expression results from a purine-free and pyrimidine-free diet and 6-mercaptopurine in the rat small intestine and colon. Gastroenterology 1987; 93: 1014-20.
35. McMillan JA, Oski FA, Lourie G, Tomarelli RM, Landaw SA. Iron absorption from human milk, simulated human milk, and proprietary formulas. Pediatrics 1977; 60: 896-900.
36. Faelli A, Esposito G. Effect of inosine and its metabolites on intestinal iron absorption in rat. Biochem Pharmacol 1970; 19: 2551-4.
37. Ohyanagi H, Nishimatsu S, Nomura H, Kawamura M. In: Gil A, Uauy R Ed, Nutritional and Biological significance of dietary nucleotides and nucleic acids. Granada, Publ. by Abbott Laboratories 1996; 145-68.
38. Ogoshi S, Omori Y, Iwasa M, Iwasa Y. In: Gil A, Uauy R Ed, Nutritional and biological significance of dietary nucleotides and nucleic acids. Granada, Publ. by Abbott Laboratories 1996; 181-90.
39. Meisel H, Günther S, Martin D, Schlimme E. Apoptosis induced by modified ribonucleosides in human cell culture systems. FEBS Lett 1998; 433: 265-8.
40. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelmann WN, et al. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine. Blood 1993; 81: 143-50.
41. Meisel H, Hartmann R, Martin D, Schlimme E. Modulating effects of adenosine and modified adenine ribonucleosides on human cells (HL-60). Nahrung 1999; 43(3): 213-5.
42. Hartmann R, Günther S, Martin D, Meisel H, Pentzien A-K, Schlimme E, Scholz N. Cytochemical model systems for the detection and characterization of potentially bioactive milk components. Kieler Milchw Forsch 2000; 52(1): 61-85.
43. Sato N, Kawakami H, Idota T. Nucleotide and nucleoside supplementation may morphologically promote the differentiation of human Caco-2 cells. J Nutr Sci Vitaminol 2000; 46(4): 175-9.
44. Arnaud A, Fontana L, Angulo A J, Gil A, Lopez-Pedrosa JM. Exogenous nucleosides alter the intracellular nucleotide pool in hepatic cell cultures. Implications in cell proliferation and function. Clin Nutr 2003; 22(4): 391-9.
45. Saez-Lara MJ, Manzano M, Angulo AJ, Suarez A, Torres MI, Gomez-Llorente C, et al. Exogenous nucleosides stimulate proliferation of fetal rat hepatocytes. J Nutr 2004; 134(6): 1309-13.
46. Chishty M, Begley DJ, Abbott NJ, Reichel A. Interaction of nucleoside analogs with nucleoside transporters in rat brain endothelial cells. J Drug Target 2004; 12(5): 265-72.
47. Lang TT, Young JD, Cass CE. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line. Mol Pharmacol 2004; 65(4): 925-33.
48. Archer RGE, Pitelka V, Hammond JR. Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells. Br J Pharmacol 2004; 143(1): 202-14.
49. Borek E. tRNA and tRNA modification in differentiation and neoplasia. Cancer Res 1971; 31: 596-7.
50. Waalkes TP, Gehrke CW. In: Gehrke CW, Kuo KCT Ed, Chromatography and modification of nucleosides; part C: modified nucleosides in cancer and normal metabolism, methods and applications. Journal of Chromatography Library Vol. 45C. Amsterdam, Elsevier Publishers 1990; C1-C13.
51. Zumwalt RW, Waalkes TP, Kuo KC, Gehrke CW. In: Gehrke CW, Kuo KCT Ed, Chromatography and modification of nucleosides; part C: modified nucleosides in cancer and normal metabolism, methods and applications. Journal of Chromatography Library Vol. 45C. Amsterdam, Elsevier Publishers 1990; C15-C40.
52. Schlimme E, Boos K-S, Schwarzenau E, Frister H, Ott FG, Raezke K-P, et al. Dual column HPLC analysis of modified ribonucleosides as urinary pathobiochemical markers in clinical research. Nucleosides & Nucleotides 1990; 9: 407-10.
53. Schwarzenau E, Schlimme E, Boos K-S, Wilmers B, Raezke K-P, Ott FG, et al. Ribonucleosidausscheidungsmuster bei Mammakarzinompatientinnen. Tumordiagn Ther 1990; 11: 198-203.
54. Schlimme E, Boos K-S. In: Gehrke CW, Kuo KCT Ed, Chromatography and modification of nucleosides; part C: modified nucleosides in cancer and normal metabolism, methods and applications. Journal of Chromatography Library Vol. 45C. Amsterdam, Elsevier Publishers 1990; C115-45.
55. Zheng Y, Xu G, Yang J, Zhao X, Pang T, Kong H. Determination of urinary nucleosides by direct injection and coupled-column high-performance liquid chromatography. J Chromatogr B 2005; 819: 85-90.
56. Yang J, Xu G, Zheng Y, Kong H, Pang T, Lv S, et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B 2004; 813: 59-65.
57. Liebich HM, Müller-Hagedorn S, Klaus F, Meziane K, Kim K-R, Frickenschmidt A, et al. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers. J Chromatogr A 2005; 1071: 271-5.
58. Zheng YF, Yang J, Zhao XJ, Feng B, Kong HW, Chen YJ, et al. Urinary nucleosides as biological markers for patients with colorectal cancer. World J Gastroenterol 2005; 11(25): 3871-6.
59. Li KM, Rivory LP, Clarke SJ. Rapid quantitation of plasma 2′- deoxyuridine by high-performance liquid chromatography / atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients. J Chromatogr B 2005; 820: 121-30.
60. Yamauchi T, Ueda T. A sensitive new method for clinically monitoring cytarabine concentrations at the DNA level in leukemic cells. Biochem Pharmacol 2005; 69: 1795-803.
61. Chambert S, Decout JL. Recent developments in the synthesis, chemical modifications and biological applications of sulfur modified nucleosides, nucleotides and oligonucleotides. Org Prep Proced Int 2002; 34(1): 27-85.
62. Gunaga P, Moon HR, Choi WJ, Shin DH, Park JG, Jeong LS. Recent advances in 4′-thionucleosides as potential antiviral and antitumor agents. Curr Med Chem 2004; 11(19): 2585-637.
63. Yokoyama M. Synthesis and biological activity of thionucleosides. Synthesis 2000; 12: 1637-55.
64. Mansour TS, Storer R. Antivirial nucleosides. Curr Pharm Des 1997; 3(2): 227-64.
65. Yokoyama M, Momotake A. Synthesis and biological activity of azanucleosides. Synthesis-Stuttgart 1999; 9: 1541-54.
66. Pogocki D, Schoneich C. Chemical stability of nucleic acid-derived drugs. J Pharm Sci 2000; 89(4): 443-56.
67. Ichikawa E, Kato K. Advance in synthesis of sugar-modified nucleosides in past 10 years. J Syn Org Chem Jpn 2001; 59(4): 331-45.
68. Hilleman MR. Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 2003; 21: 4626-49.
69. Alexander RL, Kucera GL. Lipid nucleoside conjugates for the treatment of cancer. Curr Pharm Des 2005; 11(9): 1079-89.
70. Buszewski B, Kowalska S, Krupczynska K. New generation of chromatographic packings and columns for determination of biologically active compounds. Crit Rev Anal Chem 2005; 35(2): 89-116.
71. Rais RH, Al Safarjalani ON, Yadav V, Guarcello V, Kirk M, Chu CK, et al. 6-Benzylthioinosine analogs as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities. Biochem Pharmacol 2005; 69(10): 1409-19.
72. Li SP, Li P, Lai CM, Gong YX, Kan KKW, Dong TTX, et al. Simultaneous determination of ergosterol, nucleosides and their bases from natural and cultured Cordyceps by pressurised liquid extraction and high-performance liquid chromatography. J Chromatogr A 2004; 1036: 239-43.
73. Sun YJ, Lu P, Ling JY, Zhang HX, Chen C, Zhang CK. Nucleoside form Cordyceps kyushuensis and the distribution of two active components in its different parts. Acta Pharm Sin 2003; 38(9): 690-4.
74. Chong YH, Choo H, Choi Y, Mathew J, Schinazi RF, Chu CK. Stereoselective synthesis and antiviral activity of D-2′,3′-didehydro-2′,3′- dideoxy-2′-fluoro-4′-thionucleosides. J Med Chem 2002; 45(822): 4888-98.
75. Saag MS, Tebas P, Sension M, Conant M, Myers R, Chapman SK, et al. Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). AIDS 2001; 15(15): 1971-8.
76. Walker UA, Langmann P, Miehle N, Zilly M, Klinker H, Petschner F. Beneficial effects of oral uridine in mitochondial toxicity. AIDS 2004; 18(7): 1085-6.
77. Cahours X, Dessans H, Morin P, Dreux M, Agrofoglio L. Determination at ppb level of an anti-human immunodeficiency virus nucleoside drug by capillary electrophoresis-electrospray ionization tandem mass spectrometry. J Chromatogr A 2000; 895: 101-9.
78. Rodrigues MCA, Guizzo R, Gobbo-Neto L, Ward RJ, Lopes NP, Ferreira dos Santos W. The biological activity in mammals and insects of the nucleosidic fraction from the spider Parawixia bistriata. Toxicon 2004; 43: 375-83.
79. Rauter AP, Padilha M, Figueiredo JA, Ismael MI, Justino J, Ferreira H, et al. Bioactive pseudo-C-nucleosides containing thiazole, thiazolidinone, and tetrazole rings. J Carbohydr Chem 2005; 24(3): 275-96.
80. Herbel W, Montag A. Bestimmung niedermolekular gebundener Purin- und Pyrimidinbasen in Lebensmitteln nach gelchromatographischer Isolierung und hydrolytischem Druckaufschluss. Z Lebensm Unters Forsch 1986; 183: 12-7.
81. Herbel W, Montag A. Nucleostoffe in proteinreichen Lebensmitteln. Z Lebensm Unters Forsch 1987; 185: 119-22.
82. Gosch B, Montag A. The status of nucleocompounds and its variability in meat of poultry. 1. Study about the influence of poultry species on the distribution of nucleopurines. Deut Lebensm Rundsch 1996; 92(10): 318-23.
83. Raezke K-P, Schlimme E. Ribonucleoside in Milch: Charakterisierung und Bestimmung des Konzentrationsprofils dieser minoren Komponenten über eine Lactationsperiode. Z Naturforsch 1990; 45c: 655-62.
84. Schlimme E, Raezke K-P, Ott F-G. Ribonucleosides as minor milk constituents. Z Ernahrungswiss 1991; 30(2): 138-52.
85. Martin D, Clawin-Rädecker I, Lorenzen PChr, Ziebart M, Barth K. Ribonucleosid-Gehalte in Schaf- und Ziegenmilch. Kieler Milchw Forsch 2005; 57(1): 21-32.
86. Groß H, Topp H, Heller-Schöch G, Schöch G. Modifizierte Ribonucleoside in Frauenmilch. Ernährungsumschau 1992; 39: 21.
87. Schneehagen K, Schlimme E. Ribonucleoside: Minore Inhaltsstoffe der Humanmilch. Kieler Milchw Forsch 1992; 44: 67-74.
88. Topp H, Heller-Schöch G, Schöch G. Determination of N6-threoninocarbonyladenosine, N2-N2-dimethylguanosine, pseudouridine and other ribonucleosides in human breast milk. Nucleosides Nucleotides 1993; 12: 585-96.
89. Schlimme E, Schneehagen K. Ribonucleosides in human milk-Concentration profiles of these minor constituents as a function of the nursing time. Z Naturforsch 1995; 50c: 105-13.
90. Schlimme E, Raezke K-P, Ott F-G, Schneehagen K. In: Gil A, Uauy R Ed, Nutritional and biological significance of dietary nucleotides and nucleic acids. Granada, Abbott Laboratories 1996; 69-86.
91. Schlimme E, Martin D, Meisel H, Schneehagen K, Hoffmann S, Sievers E, et al. Species-specific composition pattern of milk ribonucleosides and nucleotides: chemical and physiological aspects. Kieler Milchw Forsch 1997; 49: 305-26.
92. Leach JL, Baxter JH, Molitor BE, Ramstack MB, Masor ML. Total potentially available nucleosides of human milk by stage of lactation. Am J Clin Nutr 1995; 61: 1224-30.
93. Al-Delami OF, Banu C. Während der Sterilisation im Fleisch auftretende Veränderungen. Fleischwirtschaft 1982; 62(8): 1014-21.
94. Martin D, Kiesner C, Schlimme E. Ribonucleosides: Chemical parameters for controlling the heat treatment of milk. Nahrung 1997; 41: 258-67.
95. Ott F-G, Schlimme E. Thermisch induzierte Bildung von N6-Methyladenosin. Kieler Milchw Forsch 1991; 43: 213-7.
96. Schlimme E, Ott F-G, Kiesner C. Reaction kinetics of the heat-induced formation of N6-methyladenosine in milk. Int Dairy J 1994; 4: 617-27.
97. Martin D, Kiesner C, Schlimme E. Kinetische Analyse der Dimroth-Umlagerung des 1-Methyladenosins in Milch unter Temperatur-Zeit-Bedingungen des Sterilbereichs. Kieler Milchw Forsch 1995; 47: 75-86.
98. Martin D, Lorenzen PChr, Schwertfeger M, Buchheim W, Schlimme E. Ribonucleosidgehalte in hochdruckbehandelten Milchproben. Kieler Milchw Forsch 2001; 53: 283-93.
99. Martin D, Kiesner C, Lorenzen PChr, Schlimme E. Adenosin-Desaminase (EC 3.5.4.4): Ein potentieller Hitzeindikator zur Unterscheidung von kurzzeit- und hocherhitzter Konsummilch. Kieler Milchw Forsch 1998; 50: 225-33.
100. Schlimme E, Kiesner C, Lorenzen PChr, Martin D. Influence of heat treatment of milk on the activities of the indigenous milk enzymes alkaline phosphatase and adenosine deaminase. Bull IDF 1998; 332: 25-31.
101. Martin D, Lorenzen PChr, Kiesner C, Schlimme E. Reaktionskinetische Analyse der thermischen Inaktivierung der Milchenzyme Adenosindesaminase, Alkalische Phosphatase und γ-Glutamyltransferase. Kieler Milchw Forsch 1999; 51: 343-55.
102. Martin D, Schlimme E. Einfluss technologischer Maßnahmen auf das Aktivitätsverhalten des Milchenzyms Adenosindesaminase (ADA, EC 3.5.4.4). Kieler Milchw Forsch 2002; 54: 305-15.
103. Schlimme E, Lorenzen PChr, Martin D, Thormählen K. Differentiation of butter types by measuring specific compositional parameters of the aqueous butter phase. Milchwissenschaft 1996; 51: 139-43.
104. Meisel H, Lorenzen PChr, Martin D, Schlimme E. Chemometric identification of butter types by analysis of compositional parameters with neural networks. Nahrung 1997; 41: 75-80.
105. Martin D, Meisel H. Ringuntersuchung zur Validierung der Methode DIN 10474 "Bestimmung der Buttersorte durch neuronale Netzanalyse kompositioneller Parameter-Chemometrisches Verfahren". Kieler Milchw Forsch 2003; 55: 181-95.
106. Tressler RL, Ramstack MB, White NR, Molitor BE, Chen NR, Alarcon P, et al. Determination of Total Potentially Available Nucleosides in human milk from Asian women. Nutrition 2003; 19: 16-20.
107. Sugawara M, Sato N, Nakano T, Idota T, Nakajima I. Profile of nucleotides and nucleosides of human milk. J Nutr Sci Vitaminol 1995; 41(4): 409-18.
108. Barra PMC, Grimble GK. Nucleotides and critical care medicine. Brit J Intensive Care 2002; 12(4): 105-13.
109. Nugent JM, Joyce SM. Producing human therapeutic proteins in plastids. Curr Pharm Des 2005; 11(19): 2459-70.
110. Bioplex technology: novel synthetic gene delivery pharmaceutical based on peptides anchored to nucleic acids. Curr Pharm Des 2005; 11(28): 3671-80.
111. Wegewitz U, Gohring I, Spranger J. Novel approaches in the treatment of angiogenic eye disease. Curr Pharm Des 2005; 11(18): 2311-30.